Treatment of neovascular age related macular degeneration with intravitreal Bevacizumab (Avastin)
- Registry ID
- EUCTR2006-001914-34
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Bert Mueller, Dep. Ophthalmology
- Start date
- 2006-08-30
- Completion date
- 2008-07-31
- Last update
- 2026-08-16
Conditions
- neovascular age-related macular degeneration
Summary
To test effeciacy and safety of 1mg intravitreal Bevacizumab in patients with neovascular age related macular degeneration and recent loss of visual acuity
Locations
View on source registry